SCHEMBL30337173

SCHEMBL30337173

Cn1cc(-c2ccnc(Cl)n2)c2ccc(C#N)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.43
DYRK1A Q13627 4/20 0.42
PGR P06401 1/20 0.41
SCN9A Q15858 2/20 0.41
GSK3B P49841 3/20 0.39
AURKA O14965 1/20 0.39
JAK2 O60674 1/20 0.39
PAK4 O96013 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
LCK P06239 1/20 0.39
FYN P06241 1/20 0.39
CSF1R P07333 1/20 0.39
RET P07949 1/20 0.39
IGF1R P08069 1/20 0.39
MET P08581 1/20 0.39
PDGFRB P09619 1/20 0.39
PIM1 P11309 1/20 0.39
FGFR1 P11362 1/20 0.39
PRKACA P17612 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542577 1.00 EGFR (0.43) EGFRDYRK1APGRSCN9AGSK3B
SCHEMBL30337162 0.83 DYRK1A (0.46) EGFRDYRK1ASCN9AGSK3BJAK2
SCHEMBL28384419 0.83 DYRK1A (0.46) EGFRDYRK1ASCN9AGSK3BJAK2
SCHEMBL20610618 0.83 GRM5 (0.37) EGFRDYRK1AGSK3BMAP3K14CDK2
SCHEMBL30337212 0.82 DYRK1A (0.45) EGFRDYRK1ASCN9AGSK3BDYRK1B
SCHEMBL19254846 0.82 DYRK1A (0.45) EGFRDYRK1ASCN9AGSK3BDYRK1B
SCHEMBL17490471 0.82 DYRK1A (0.45) EGFRDYRK1ASCN9AGSK3BAURKA
SCHEMBL17683321 0.81 DYRK1A (0.44) EGFRDYRK1ASCN9AGSK3BIGF1R
SCHEMBL30459718 0.81 DYRK1A (0.44) EGFRDYRK1ASCN9AGSK3BIGF1R
SCHEMBL28987593 0.79 DYRK1A (0.44) EGFRDYRK1ASCN9AGSK3BIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed